Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
L. Pini (Brescia (BS), Italy), L. Corda (Brescia (BS), Italy), G. Levi (Brescia (BS), Italy), L. Tiberio (Brescia (BS), Italy), C. Rocchetti (Brescia (BS), Italy), M. Arici (Brescia (BS), Italy), J. Giordani (Brescia (BS), Italy), C. Tantucci (Brescia (BS), Italy). Z-alpha1-antitrypsin polymers and small airways disease: a new paradigm in COPD development?. 965

Member's Comments

No comment yet.

Related content which might interest you: The role of cluster analysis in defining phenotypes of obstructive airway diseases: is there a need for a new taxonomy of obstructive airway diseases? Source: Annual Congress 2011 - PG11 Update of phenotypes of asthma and COPD Year: 2011 Mucosal cryobiopsies: A novel method for studying obstructive airways disease? Source: International Congress 2017 – Innovation in COPD: techniques and facts Year: 2017 Dismantling airway disease with the use of new pulmonary function indices Source: Eur Respir Rev, 28 (151) 180122; 10.1183/16000617.0122-2018 Year: 2019 The overlap between bronchiectasis and chronic airway diseases: state of the art and future directions Source: Eur Respir J, 52 (3) 1800328; 10.1183/13993003.00328-2018 Year: 2018 Human small airway-on-a-chip: A novel microphysiological system to model lung inflammation, accelerate drug development and enable inhalational toxico-analysis Source: International Congress 2016 – Therapeutic horizons: novel targets and pharmacological models Year: 2016 Asthma and chronic obstructive pulmonary disease training in an online environment: a new response to a growing problem Source: International Congress 2019 – Nursing care across the spectrum of respiratory illnesses Year: 2019 Cleaning agents and chronic lung disease: does the evidence support a link with COPD? Source: International Congress 2018 – Cleaning agent exposures: are they really harmful to lung health? Year: 2018 A new piece in the puzzle: the eosinophil and the development of COPD Source: Eur Respir J, 58 (4) 2101105; 10.1183/13993003.01105-2021 Year: 2021 Subphenotyping COPD: is it relevant for therapeutic intervention and disease outcome? Source: Annual Congress 2005 - Inflammatory phenotypes of asthma and COPD: the end of traditional diagnosis, or not? Year: 2005 Chronic diseases like asthma and COPD: do they truly exist? Source: Eur Respir J 2016; 47: 359-361 Year: 2016 What are the common biological mechanisms that lead to obstructive airway disease? Source: International Congress 2016 – Early life origins of asthma and COPD Year: 2016 Challenging the paradigm: moving from umbrella labels to treatable traits in airway disease Source: Breathe, 17 (3) 210053; 10.1183/20734735.0053-2021 Year: 2021 Defining severe obstructive lung disease in the biologic era: an endotype-based approach Source: Eur Respir J, 54 (5) 1900108; 10.1183/13993003.00108-2019 Year: 2019 Novel insights into the genetics of smoking behaviour, lung function and chronic obstructive pulmonary disease in UK Biobank Source: International Congress 2015 – Asthma: emerging risk factors and current management of the patient Year: 2015 The lung microbiome in obstructive airways disease: potential pathogenetic roles Source: Eur Respir Monogr 2019; 83: 140-157 Year: 2019 Application of omics technologies to the identification of biomarkers for COPD Source: Annual Congress 2007 - Cell biology of asthma and COPD Year: 2007 Extent of inhaled drug deposition in mouth-throat and pulmonary airways: A novel biophysical modelling approach for inhaled therapeutics Source: International Congress 2015 – New models for treating airway diseases Year: 2015 Small airways and early origins of COPD: pathobiological and epidemiological considerations Source: Eur Respir J, 55 (3) 1902457; 10.1183/13993003.02457-2019 Year: 2020